徳島大学大学院医歯薬学研究部 医学域 医科学部門 生理系 薬理学分野
Department of Pharmacology, Tokushima University Graduate School of of Biomedical Sciences

Research Themes
We're currently promoting the following research themes.

(1)Research on the pathophysiological significance of iron
The analysis of iron metabolism changes in disease states and iron-regulated treatment in animal models has revealed that iron-depleting drugs promote angiogenesis (Ikeda, et al. Atherosclerosis. 2011), suppress oxidative stress and have anti-obesity and anti-diabetic effects (Tajima and Ikeda, et al. Am J Physiol Endocrinol Metab. 2012), and have anti-kidney fibrosis effects (Ikeda and Ozono, et al. PlosOne 2014). Physiol Endocrinol Metab. 2012), anti-renal fibrosis (Ikeda and Ozono, et al. PlosOne 2014), diabetic kidney disease due to dietary iron restriction (Ikeda and Enomoto, et al. Am J Physiol Renal Physiol 2013) and protein-loaded renal interstitial disorders (Ikeda, et al. Sci Rep 2017). Involved in iron oxidative stress-HIF-2α-mediated regulation of erythropoietin expression (Oshima and Ikeda, et al. Lab Invest. 2017), promotion of skeletal muscle degradation by iron excess (Ikeda and Imao, et al. J Trace Elem Med Biol. 2016) and differentiation inhibition (Ikeda and Satoh, et al. FASEB J. 2019) molecular mechanisms. We also reported that macrophage-derived iron stress plays a major role in the development and progression of obesity and diabetes (Ikeda and Watanabe, et al. Diabetologia. 2020). We found that ferrotosis is involved in cisplatin kidney injury (Ikeda, et al. J Trace Elem Med Biol. 2021).
・Research on iron (1, 2)
・Research on epigenetic control mechanisms (3)
・Research on Wakan-yaku (4)
・Iron Metabolic Transformation in Low Gravity Environment (5)

(2)Research on regulatory mechanisms of iron metabolism
Using various pathological models of female postmenopause, chronic kidney disease, and hypertension, the female hormone estrogen (Ikeda, et al. PlosOne 2012), urinary toxins (Hamano and Ikeda, et al. Ikeda, et al. Nephrol Dial Transplant. 2018) angiotensin II (Tajima, et al. Eur J Nutr. 2015) cause ectopic iron accumulation by causing changes in systemic iron metabolism via hepatic hepcidin regulation. Gastric acid secretion inhibitor proton pump inhibitors cause iron deficiency, and the mechanism of iron deficiency was shown to suppress gastrointestinal iron absorption by increasing hepcidin production (Hamano and Ikeda, et al. Tocixol lett. 2020).
(5)Iron Metabolic Transformation in Low Gravity Environment
来たるべき宇宙時代において、微小重力,低重力の環境における生体恒常性変化を解明することが必須である。鉄は必須微量金属元素であるが、宇宙環境では貧血や宇宙放射線などによる鉄が触媒する酸化ストレスが増悪するといわれている。そのため、NASAでは鉄摂取量を定めている。
JAXAマウスサンプルシェアに採択され、低呪力環境におかれたマウスの消化管、胸骨肋骨を用いて、消化管鉄吸収の変化について解析を行っている(投稿中)。この研究で得られた結果から、寝たきり状態における病態解析への応用が期待できる。
